Article
Mutant cell surface receptors as targets for individualized cancer diagnosis and therapy.
Current cancer drug targets - 1 Aug 2001
Becker K F, Höfler H
Abstract excerpt
The catalogue of gene alterations in human cancer is growing rapidly. Alterations in specific genes that play important roles in diverse cellular functions such as cell adhesion, signal transduction, differentiation, development or DNA-repair have been identified. Cancer-associated mutant cell surface molecules are very attractive candidates to target tumor cells because they offer the possibility of minimizing...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
